Semnur Pharmaceuticals, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $0 | $0 | — | — |
| Jun 2022 | $-218.6K | $-218.6K | — | — |
| Sep 2022 | $-41.6K | $-41.6K | — | — |
| Mar 2023 | $-240.4K | $-240.4K | — | — |
| Jun 2023 | $-157.7K | $-157.7K | — | — |
| Sep 2023 | $-75.7K | $-75.7K | — | — |
| Mar 2024 | $-374.2K | $-374.2K | — | — |
| Jun 2024 | $-114.5K | $-114.5K | — | — |
| Sep 2024 | $-3.0M | $-3.0M | — | — |
| Mar 2025 | $-399.0K | $-399.0K | — | $92.0K |
| Jun 2025 | $268.0K | $268.0K | — | — |
| Sep 2025 | $-2.1M | $-2.1M | — | — |
| Mar 2026 | $-2.7M | $-2.7M | — | $1.5M |
| Jun 2026 | $-2.1M | $-2.1M | — | — |